同胞卵母细胞多年结局显示简化培养系统安全有效,与低成本体外受精环境中的应用一致
本分析为一项非劣效性前瞻研究的一部分,在选定患者中将同胞卵母细胞随机分配至胞浆内单精子注射(ICSI)或简化培养系统(SCS)授精。2016年1月至2019年12月共653个SCS/ICSI周期、7915枚卵母细胞,SCS与ICSI的持续妊娠率、植入率和流产率无显著差异。
要点
- SCS与ICSI的持续妊娠率分别为32.0%和36.7%(P=0.27),无显著差异。
- SCS受精率61.1%高于ICSI的50.4%(P<0.0001)。
- SCS与ICSI的植入率分别为30.6%和34.4%(P=0.35),流产率分别为7.5%和6.5%(P=0.75)。
核心结论
- 在该选定患者队列中,SCS与ICSI的持续妊娠率、植入率和流产率无差异。
研究设计与样本
- 本分析为一项非劣效性前瞻研究的一部分,比较ICSI与简化培养系统(SCS)的配子受精。
- 按方案将完整卵丘-卵母细胞复合体中的同胞卵母细胞随机分配至ICSI和SCS常规授精。
- 主要结局为每周期持续妊娠率(>12周),次要结局包括受精率、流产率和植入率(每胚胎持续妊娠率)。
- 2016年1月至2019年12月共进行653个SCS/ICSI周期,获得7915枚卵母细胞。
主要发现
- SCS受精率为61.1%,ICSI为50.4%(P<0.0001)。
- SCS持续妊娠率为32.0%,ICSI为36.7%(P=0.27)。
- SCS植入率为30.6%,ICSI为34.4%(P=0.35)。
- SCS流产率为7.5%,ICSI为6.5%(P=0.75)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can a novel closed simplified IVF culture system be used to achieve outcomes comparable to those obtained with intracytoplasmic sperm injection (ICSI) followed by conventional culturing? DESIGN: This analysis is part of a non-inferiority prospective study comparing ICSI and a simplified culture system (SCS) for gamete fertilization in a selected group of patients. According to protocol, sibling oocytes in intact cumulus-oocyte complexes were randomly distributed between ICSI and conventional insemination in the SCS. For women, selection criteria included being under 43 years of age and at least six eggs at retrieval. An inseminating motile sperm count ≥1 million was required. The primary outcome measure was ongoing pregnancy rate (>12 weeks) per cycle; secondary outcome measures included fertilization rate, miscarriage rate and implantation rate (ongoing pregnancy rate per embryo). RESULTS: From January 2016 until December 2019, 653 SCS/ICSI cycles were performed yielding a total of 7915 oocytes. The fertilization rate was 61.1% and 50.4% for SCS and ICSI (P < 0.0001), respectively. The ongoing pregnancy rate was 32.0% for SCS and 36.7% for ICSI (P = 0.27). Implantation rate was 30.6% for SCS and 34.4% for ICSI (P = 0.35). The miscarriage rate was 7.5% and 6.5% for SCS and ICSI, respectively (P = 0.75). CONCLUSION: No difference was found in ongoing pregnancy rate, implantation rate and the miscarriage rate between SCS and ICSI in this selected patient cohort.
引用
- Ombelet W, Van Blerkom J, Nargund G, et al. Multiyear outcomes using sibling oocytes demonstrates safety and efficacy of a simplified culture system consistent with use in a low-cost IVF setting. Reprod Biomed Online. 2022. PMID: 36064261. doi:10.1016/j.rbmo.2022.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。